Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) enabling access to life-changing gene therapies by helping bring them from concept to reality. Headquartered in Columbus, Ohio, Forge operates the Hearth, a 200,000-square-foot facility with 20 custom-designed cGMP suites and 20,000 L of bioreactor capacity. Forge provides end-to-end AAV development and manufacturing services from research scale through commercial production, leveraging its proprietary FUEL™ platform designed to get more doses from every run. Forge is part of Ajinomoto Bio-Pharma Services, a global network of specialized CDMOs within the Ajinomoto Group. To learn more, visit www.forgebiologics.com.